Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: Evidence for a functionally diverse allorestricted T cell repertoire

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2432-2443

  Obst, Reinhard ^a   Münz, Christian ^a   Stevanović, Stefan ^a   Rammensee, Hans Georg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alloreactivity; Cancer immunotherapy; Cytotoxic T lymphocyte; MHC; Peptide library

Indexed keywords

PEPTIDE LIBRARY; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; H-2 ANTIGENS; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGOPEPTIDES; PEPTIDE LIBRARY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031927388     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0     Document Type: Article

References (56)

1. Sherman, L. A. and Chattopadhyay, S., The molecular basis of allorecognition. Annu. Rev. Immunol. 1993. 11: 385-402.
2. Matzinger, P. and Bevan, M. J., Hypothesis: Why do so many lymphocytes respond to major histocompatiblity antigens? Cell. Immunol. 1977. 29: 1-5.
3. Bevan, M. J., High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 1984. 5: 128-129.
4. Kaye, J. and Janeway Jr., C. A., The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide linked heterodimer from a helper T cell clone blocks activation by either allogeneic la or antigen and self-la. J. Exp. Med. 1984. 159: 1397-1412.
5. b by alloreactive cytotoxic T lymphocytes. Nature 1989. 341: 749-752.
6. Heath, W. R., Kane, K. P., Mescher, M, F. and Sherman, L. A., Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 1991. 88: 5101-5105.
7. Heath, W. R. and Sherman, L. A., Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur. J. Immunol. 1991. 21: 153-159.
8. Aosai, F., Öhlén, C., Ljunggren, H.-G., Höglund, P., Franksson, L., Ploegh, H. L., Townsend, A., Kärre, K. and Stauss, H. J., Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur. J. Immunol. 1991. 21: 2767-2774.
9. Rötzschke, O., Falk, K., Faath, S. and Rammensee, H.-G., On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 1991. 174: 1059-1071.
10. Crumpacker, D. B., Alexander, J., Cresswell, P. and Engelhard, V. H., Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174 x CEM.T2. J. Immunol. 1992. 148: 3004-3011.
11. Man, S., Salter, R. D. and Engelhard, V. H., Role of endogenous peptide in human alloreactive cytotoxic T lymphocyte responses. Int. Immunol. 1992. 4: 367-375.
12. Guimezanes, A., Schumacher, T. N. M., Ploegh, H. L. and Schmitt-Verhulst, A. M., A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I molecule. Eur. J. Immunol. 1992. 22: 1651-1654.
13. Chattopadhyay, S., Theobald, M., Biggs, J. and Sherman, L. A., Conformational differences on major histocompatibility complex-peptide complexes can result in allorecognition. J. Exp. Med. 1994. 179: 213-219.
14. Demotz, S., Sette, A., Sakaguchi, K., Buchner, R., Appella, E. and Grey, H. M., Self peptide requirement for class II major histocompatibility complex allorecognition. Proc. Natl. Acad. Sci. USA 1991. 88: 8730-8734.
15. Panina-Bordignon, P., Corradin, G., Roosnek, E., Sette, A. and Lanzavecchia, A., Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science 1991. 252: 1548-1550.
16. + T cell recognition of class II MHC molecules. J. Immunol. 1995. 154: 5153-5164.
17. Elliott, T. and Eisen, H. N., Cytotoxic T lymphocytes recognize a reconstituted class I histocompatiblity antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad. Sci. USA 1990. 87: 5213-5217.
18. Smith, P. A., Brunmark, A., Jackson, M. and Potter, T. A., Peptide-independent recognition by alloreactive cytotoxic T lymphocytes. J. Exp. Med. 1997. 185: 1023-1034.
19. Henderson, R. A., Cox, A. L., Sakaguchi, A., Appella, E., Shabanowitz, J., Hunt, D. F. and Engelhard, V. E., Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1993. 90: 10275-10279.
20. Aldrich, C. J., DeCloux, A., Woods, A. S., Cotter, R. J., Soloski, M. J. and Forman, J., Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994. 79: 649-658.
21. Poindexter, N. J., Neziruddin, B., McCourt, D. W. and Mohankumar, T., Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J. Immunol. 1995. 154: 3880-3887.
22. + T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. J. Immunol. 1996. 157: 4464-4473.
23. +-T cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma. Proc. Natl. Acad. Sci. USA 1996. 93: 13991-13996.
24. b. J. Immunol. 1997. 158: 2183-2191.
25. + cytotoxic T cell with apparent high affinity. J. Immunol. 1997. 158: 5797-5804.
26. Dos Reis, G. A. and Shevach, E. M., Antigen presenting cells from nonresponder strain 2 guinea pigs are fully competent to present bovine insulin B chain to responder strain 13 T cells. Evidence against a determinant selection model and in favour of a clonal deletion model of immune response gene function. J. Exp. Med. 1983. 157: 1287-1299.
27. Groves, E. S. and Singer, A., Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens. J. Exp. Med. 1983. 158: 1483-1497.
28. Matzinger, P., Zamoyska, R. and Waldmann, H., Self tolerance is H-2-restricted. Nature 1984. 308: 738-741.
29. Rammensee, H.-G. and Bevan, M. J., Evidence from in vitro studies that tolerance to self antigens is MHC-restricted. Nature 1984. 308: 741-744.
30. Rammensee, H.-G., Tissue specific cytotoxic T-cells produced by subtractive immunization in vitro. In Rammensee, H.-G., Bachmann, J. and Stevanović, S. (Eds.) MHC Ligands and Peptide Motifs. Landes, Austin, TX 1997, pp 375-380.
31. Sadovnikova, E. and Stauss, H. J., Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 1996. 93: 13114-13118.
32. Rammensee, H.-G., Lesley, J., Trowbridge, I. S. and Bevan, M. J., Antibodies against the transferrin receptor block the induction of cytotoxic T lymphocytes. A new method for antigen-specific negative selection in vitro. Eur. J. Immunol. 1985. 15: 687-692.
33. Bellone, B., Iezzi, G., Manfredi, A. A., Protti, M. P., Dellabona, P., Casorati, G. and Rugarli, C., Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody. Eur. J. Immunol. 1994. 24: 2691-2698.
34. Falk, K., Rötzschke, O., Stevanović., S., Jung, G. and Rammensee, H.-G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
35. Gavin, M. J., Dere, B., Grandea III, A. G., Hogquist, K. A. and Bevan, M. J., Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope. Eur. J. Immunol. 1994. 24: 2124-2133.
36. Udaka, K., Wiesmüller, K.-H., Kienle, S., Jung, G. and Walden, P., Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex libraries. J. Exp. Med. 1995. 181: 2097-2108.
37. Carbone, C. R., Moore, M. W., Sheil, M. J. and Bevan, M. J., Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 1988. 167: 1767-1779.
38. Staerz, U. D., Zepp, F., Schmid, R., Hill, M. and Rothbard, J., Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide. Eur. J. Immunol. 1989. 19: 2191-2196.
39. Falk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G. and Rammensee, H.-G., Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 1991. 174: 425-434.
40. Schild, H., Norda, M., Deres, K., Falk, K., Rötzschke, O., Wiesmüller, K.-H., Jung, G. and Rammensee, H.-G., Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. Exp. Med. 1991. 174: 1665-1668.
41. - strains. Proc. Natl. Acad. Sci USA 1994. 91: 11482-11486.
42. b-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 1992. 22: 2663-2667.
43. Bowness, P., Allen, R. L. and McMichael, A. J., Identification of T cell receptor recognition residues for a viral peptide presented by HLA-B27. Eur. J. Immunol. 1994. 24: 2357-2363.
44. Brock, R., Wiesmüller, K.-H., Jung, G. and Walden, P., Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T cell receptor. Proc. Natl. Acad. Sci. USA 1996. 93: 13108-13113.
45. Sykulev, Y., Brunmark, A., Tsomides, J., Kageyama, S., Jackson, M., Peterson, P. A. and Eisen, H. N., High affinity reactions between antigen-specific T cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 1994. 91: 11487-11491.
46. Alberti, S., A high affinity T cell receptor? Immunol. Cell Biol. 1995. 74: 292-297.
47. Alexander-Miller, M. A., Burke, K., Koszinowski, U. H., Hansen, T. H. and Connolly, J. M., Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J. Immunol. 1993. 151: 1-10.
48. Weiden, P. L., Flourney, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D. and Storb, R., Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979. 300: 1068-1073.
49. Weiden, P. L., Sullivan, K. M., Flourney, N., Storb, R., Thomas, E. D. and the Seattle Marrow Transplant Team, Antileukemic effect of chronic graft-versus-host disease. N. Engl. J Med. 1981. 304: 1529-1533.
50. Kolb, H.-J., Mittermüller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M. and Wilmanns, W., Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990. 76: 2462-2465.
51. Kolb, H.-J., Schattenberg, A., Goldman, J. M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., van Rhee, F., Mittermueller, J., de Witte, T., Holler, E. and Ansari, H. for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995. 86: 2041-2050.
52. Mackinnon, S., Papadopoulos, E. B., Carabasi, M. H., Reich, L., Collins, N. H., Boulad, F., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Kernan, N. A., Small, T. N., Young, J. W. and O'Reilly, R. J., Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995. 86: 1261-1268.
53. Trowbridge, I. S., Lesley, J. and Schulte, R., Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody. J. Cell. Physiol. 1982. 112: 403-410.
54. Ljunggren, H.-G. and Kärre, K., Host resistance directed selectively against H-2 deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 1985. 162: 1745-1759.
55. Rammensee, H.-G., Schild, H. and Theopold, U., Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of β-galactosidase. Immunogenetics 1989. 30: 296-302.
56. MacDonald, H. R., Cerottini, J.-C., Ryser, J.-E., Maryanski, J. L., Taswell, C., Widmer, M. B. and Brunner, K. D., Quantitation and cloning of cytolytic T lymphocytes and their precursors, Immunol. Rev. 1980. 51: 93-123.